what semaglutide is approved for weight loss The FDA has approved a

However, any underlying risk factors for microbial overgrowth, such as IBS or prior gut infections, may still be present and can continue to influence SIBO, IMO, or related symptoms

This has far-reaching effects, from maintaining healthy skin to supporting sharp cognitive function

(2022) Alpha-Cell Paracrine Signaling in the Regulation of Beta-Cell Insulin Secretion

This leads to common aging signs like fatigue, weakened immunity, slower healing, and age-related diseases

It plays a role not only in protecting against oxidative stress but also in detoxification processes

As of 2025, it remains in Phase 3 clinical trials globally and has not received approval from the Therapeutic Goods Administration (TGA)